Natural product-derived therapy for H. pylori–induced Gastric cancer: Curcumin, one of the main components of Turmeric, inhibits WNT-SOX9 pathway, decreases oncogenic β-catenin levels, suppresses H. pylori-induced gastric cancer proliferation, inhibits acquisition of tumor-initiating stem-cell properties and decreases chemoresistance via up regulation of its target gene, 3/January/2017, 1.24 pm

Natural product-derived Immune enhancement therapy: Oleanolic acid, found in Syzygium S. or Jawa apple and among others, increases SOX2 expression and promotes innate immunity against bacterial infection via down-regulation of its target gene, 3/January/2017, 1.03 pm
January 3, 2017
Life-extension therapy: Pioglitazone, an antidiabetic medication, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 3/January/2017, 1.41 pm
January 3, 2017
Show all

From Research findings to Therapeutic opportunity: 

The study presented here suggests that Curcumin, by increasing the expression of its target genes, it may: (i) inhibit WNT-SOX9 oncogenic pathway; (ii) decrease oncogenic β-catenin protein levels; (iii) decrease H. pylori-induced gastric cancer cell proliferation; (iv) inhibit acquisition of tumor-initiating stem-cell properties; and (v) decrease chemoresistance.

price-5

[easy_payment currency=”USD”]

Thereby, it may inhibit proliferation of H.Pylori-induced gastric cancer cells. Thus, pharmacological formulations encompassing Curcumin or analogues or Curcumin in combination with  any other anticancer drugs” may be used to inhibit cancer progression (Fig. 1).

Curcumin, one of the main component of Turmeric,

Figure 1.Turmeric functions as an anticancer agent in H.Pylori-induced gastric cancer. Curcumin, isolated from Turmeric, promotes Chemosensitivity via inhibition of WNT-SOX9 oncogenic pathway

Details of the research findings

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Undisclosed information: How Curcumin inhibits the WNT-SOX9 oncogenic pathway?

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $5

For purchase and payment details, you may reach us at info@genomediscovery.org

# Research cooperation


References

CitationBoominathan, L., Natural product-derived therapy for H. pylori –induced Gastric cancer: Curcumin, one of the main components of Turmeric, inhibits WNT-SOX9 pathway, decreases oncogenic β-catenin levels, suppresses H. pylori-induced gastric cancer proliferation,  inhibits acquisition of tumor-initiating stem-cell properties and decreases chemoresistance via up regulation of its target gene, 3/January/2017, 1.23 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.